Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration

Duchenne muscular dystrophy and the mdx mouse myopathies reflect a lack of dystrophin in muscles. However, both contain sporadic clusters of revertant fibers (RFs) that express dystrophin. RF clusters expand in size with age in mdx mice. To test the hypothesis that the expansion of clusters is achieved through the process of muscle degeneration and regeneration, we analyzed muscles of mdx mice in which degeneration and regeneration were inhibited by the expression of micro-dystrophins or utrophin transgenes. Postnatal RF expansion was diminished in direct correlation to the protective effect of the transgene expression. Similarly, expansion of RFs was inhibited when muscle regeneration was blocked by irradiation. However, in irradiated muscles, irradiation-tolerant quiescent muscle precursor cells reactivated by notexin effectively restored RF expansion. Our observations demonstrate that revertant events occur initially within a subset of muscle precursor cells. The proliferation of these cells, as part of the regeneration process, leads to the expansion of RF clusters within degenerating muscles. This expansion of revertant clusters depicts the cumulative history of regeneration, thus providing a useful index for functional evaluation of therapies that counteract muscle degeneration.

[1]  A. Petrie,et al.  Stem Cell Function, Self-Renewal, and Behavioral Heterogeneity of Cells from the Adult Muscle Satellite Cell Niche , 2005, Cell.

[2]  M. Maeda,et al.  Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain , 1996, Human Genetics.

[3]  Susan C. Brown,et al.  Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle , 2003, Neuromuscular Disorders.

[4]  G. Dickson,et al.  Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. , 2002, Biochemical and biophysical research communications.

[5]  A. Fassati,et al.  Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site , 2002, The Journal of cell biology.

[6]  T. Rando The dystrophin–glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies , 2001, Muscle & nerve.

[7]  G. Crawford,et al.  Suppression of revertant fibers in mdx mice by expression of a functional dystrophin. , 2001, Human molecular genetics.

[8]  J. Morgan,et al.  Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. , 2000, Journal of cell science.

[9]  S. Wilton,et al.  Massive Idiosyncratic Exon Skipping Corrects the Nonsense Mutation in Dystrophic Mouse Muscle and Produces Functional Revertant Fibers by Clonal Expansion , 2000, The Journal of cell biology.

[10]  George Bou-Gharios,et al.  Potentiation of myoblast transplantation by host muscle irradiation is dependent on the rate of radiation delivery , 1999, Cell and Tissue Research.

[11]  T. Partridge,et al.  Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation , 1999, Journal of the Neurological Sciences.

[12]  D. Israeli,et al.  Computerised dystrophic muscle simulator: prospecting potential therapeutic strategies for muscle dystrophies using a virtual experimental Model , 1999, The journal of gene medicine.

[13]  Nicolas Deconinck,et al.  Expression of full-length utrophin prevents muscular dystrophy in mdx mice , 1998, Nature Medicine.

[14]  K. Campbell,et al.  Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer. , 1998, Molecular cell.

[15]  G. Dickson,et al.  Effective restoration of dystrophin‐associated proteins in vivo by adenovirus‐mediated transfer of truncated dystrophin cDNAs , 1998, FEBS letters.

[16]  N. Laing,et al.  Dystrophin gene transcripts skipping the mdx mutation , 1997, Muscle & nerve.

[17]  K. Davies,et al.  Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene , 1996, Nature.

[18]  M. Passos-Bueno,et al.  Absence of correlation between utrophin localization and quantity and the clinical severity in Duchenne/Becker dystrophies. , 1995, American journal of medical genetics.

[19]  H. Klamut,et al.  Cloning and characterization of alternatively spliced isoforms of Dp71. , 1995, Human molecular genetics.

[20]  L. Kunkel,et al.  Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. , 1995, Human molecular genetics.

[21]  R Minami,et al.  Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. , 1994, The Journal of clinical investigation.

[22]  L. Nicholson The “rescue” of dystrophin synthesis in boys with Duchenne muscular dystrophy , 1993, Neuromuscular Disorders.

[23]  T. Vulliamy,et al.  Exon skipping and translation in patients with frameshift deletions in the dystrophin gene. , 1993, American journal of human genetics.

[24]  A. Clarke,et al.  Immunohistological evidence for second or somatic mutations as the underlying cause of dystrophin expression by isolated fibres in Xp21 muscular dystrophy of Duchenne-type severity , 1993, Journal of the Neurological Sciences.

[25]  L. Kunkel,et al.  An alternative dystrophin transcript specific to peripheral nerve , 1993, Nature Genetics.

[26]  A. Monaco,et al.  Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. , 1992, Human molecular genetics.

[27]  J. Mendell,et al.  Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. , 1992, American journal of human genetics.

[28]  C. Caskey,et al.  Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. , 1992, Nucleic acids research.

[29]  D. Watt,et al.  X‐Irradiation improves mdx mouse muscle as a model of myofiber loss in DMD , 1991, Muscle & nerve.

[30]  J. Ellis,et al.  Specificity of dystrophin analysis improved with monoclonal antibodies , 1990, The Lancet.

[31]  Simon C Watkins,et al.  Somatic reversion/suppression of the mouse mdx phenotype in vivo , 1990, Journal of the Neurological Sciences.

[32]  F. Muntoni,et al.  Transcription of the dystrophin gene in Duchenne muscular dystrophy muscle , 1989, FEBS letters.

[33]  E A Barnard,et al.  The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.

[34]  L. Kunkel,et al.  Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus , 1989, Nature.

[35]  P. Einat,et al.  Duchenne muscular dystrophy gene product is not identical in muscle and brain , 1989, Nature.

[36]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[37]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[38]  A. Monaco,et al.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.

[39]  K. Moore,et al.  X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.